Latanoprost Timolol eye drops recall

A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA).

The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an ‘out of specification result for an unknown impurity’ that was identified during testing. Medical professionals are to stop providing the eye drops to patients, and suppliers and distributors are to cease moving the eye drops as well.

The NHS has been pushing the news throughout the Service to ensure batches affected by the Latanoprost Timolol eye drops recall are not used.

Batch affected by the Latanoprost Timolol eye drops recall

The information for the batch affected by the Latanoprost Timolol eye drops recall is as follows:

Batch Number: 087B087 (pack size 1 x 2.5 mL)

First Distrusted: 15^th June 2017

Expiry Date: January 2019

You can read the advice letter issued here.

Latanoprost Timolol eye drops recall announcement

The Latanoprost Timolol eye drops recall has been announced as a Class 3 Medicines Recall by the MHRA. Stocks of the eye drops are to be quarantined and returned for replacements to be issued.

A worrying factor may be that the batch affected by the recall appears to have been first disrupted almost a year before the recall was announced. If the recalled batch may put a user at risk if they use the eye drops, we could be looking at a bigger problem if anyone suffers any adverse effects.

No issues have been reported so far, but although the recalls are intended to make sure that supplies are stopped, and affected batches are quarantined in such recalls, it’s not always so easy to get the message out to the actual people who use the products. We know about the Latanoprost Timolol eye drops recall because we monitor such things as a firm of Group Action lawyers who often engage in medical product litigation, but users are at risk when they have no idea that there’s a problem.

This is always a worrying aspect of any medical product or drugs recall.